Tradestie Institutional Equity Comparison Engine
NMAD vs BBLG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMAD Overall Edge
NMAD Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NMAD (NMAD) driven by superior Momentum & Technical, Options & Structure while BBLG counters with relative strength in Growth & Margin. Fundamentally, NMAD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BBLG at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NMAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BBLG sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NMAD N/M vs BBLG N/M Fwd P/E
Growth & Margin Winner
BBLG
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
NMAD
1Y -65.1% vs -82.9% ยท 52W Pos 8% vs 0%
Options & Structure Winner
NMAD
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
NMAD
US Equity
NMAD
Institutional Equity
$2.56
+13.53% 1D
Market Cap
N/A
1M Return
-28.89%
1Y Return
-65.12%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 70.0
BBLG
NASDAQ
Bone Biologics Corp Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.27
-2.4% 1D
Market Cap
$932,329
1M Return
-33.8%
1Y Return
-82.9%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 33.0
Fund 48.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMAD -65.12%
BBLG -82.9%
Spread: +16.23 pp (NMAD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NMAD TTM Op. Margin: N/A
BBLG TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMAD vs BBLG. Trailing 12-month operating profitability (NMAD N/A vs BBLG 0.0%) and valuation multiples (NMAD N/M vs BBLG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMAD | BBLG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $932,329 | Larger Scale | BBLG |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | BBLG |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | BBLG |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | BBLG |
| Return on Equity (ROE) Capital Efficiency | N/A | -47.5% | Higher ROE | BBLG |
| 52-Week Range Position Momentum | 8% ($2โ$8) | 0% ($0โ$2) | Stronger Trend | NMAD |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 173% Vol | 0.97ฮฒ ยท 102% Vol | Lower Realized Risk | BBLG |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 44.8 / 100 (HOLD) | Higher Composite | NMAD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMAD vs BBLG Buy Guide
NMAD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BBLG
BREAKDOWN
104d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMAD nor BBLG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.